Aim: ESBL-producing and bacterial biofilms-forming Escherichia coli are associated with antimicrobial treatment failure. This study aimed to investigate the phenotypic resistance mechanisms of CTX-M E. coli against old antibiotics-cell wall synthesis inhibitors temocillin, nitrofurantoin and fosfomycin. Materials & Methods: Susceptibility to old antibiotics testing was performed using disk diffusion method, biofilm formation was evaluated spectrophotometrically, and PCR was used for the determination of CTX-M type. Results & conclusion: Temocillin was active against nearly 93%, nitrofurantoin and fosfomycin, respectively, 91.7% and 98.6% of tested E. coli. Thus, it demonstrated to be a good alternative therapeutic option against ESBL infections. Bacteria resistant to old antibiotics had CTX-M-15 or CTX-M-15, TEM-1 and OXA-1 combinations. No significant association was found between CTX-M E. coli resistance to temocillin, nitrofurantoin and fosfomycin; however, the level of biofilm formation was found as not affected by the type of CTX-M-lactamases.
CITATION STYLE
Giedraitiene, A., Pereckaite, L., Bredelyte-Gruodiene, E., Virgailis, M., Ciapiene, I., & Tatarunas, V. (2022). CTX-M-producing Escherichia coli strains: Resistance to temocillin, fosfomycin, nitrofurantoin and biofilm formation. Future Microbiology, 17(10), 789–802. https://doi.org/10.2217/fmb-2021-0202
Mendeley helps you to discover research relevant for your work.